Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique L Monnet

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
The Lancet. Infectious Diseases|March 28, 2014
Drug-resistant Salmonella enterica serotype Kentucky in EuropeTherese Westrell, Dominique L Monnet, Céline Gossner, et al.
British Journal of Clinical Pharmacology|May 4, 2006
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospitalArno Muller, Dominique L Monnet, Daniel Talon, et al.
The Lancet. Infectious Diseases|December 3, 2014
Antibiotic use worldwideLiselotte Diaz Högberg, Arno Muller, Anna Zorzet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2015
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015Barbara Albiger, Corinna Glasner, Marc J Struelens, et al.
Diagnostic Microbiology and Infectious Disease|April 22, 2014
Antimicrobial resistance surveillance in Europe: regional pooling of national data from a small number of sites can be misleadingLiselotte Diaz Högberg, Anna-Pelagia Magiorakos, Ole E Heuer, et al.
Antimicrobial Resistance and Infection Control|February 16, 2013
The rise of carbapenem resistance in Europe: just the tip of the iceberg?Anna-Pelagia Magiorakos, Carl Suetens, Dominique L Monnet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 19, 2021
Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020Liselotte Diaz Högberg, Vera Vlahović-Palčevski, Cátia Pereira, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 15, 2024
Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021Igor Rubinić, Vivian H Leung, Liselotte Diaz Högberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 13, 2020
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant <i>Acinetobacter baumannii</i> in Europe, 2019Felix Lötsch, Barbara Albiger, Dominique L Monnet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 18, 2022
Large increase in bloodstream infections with carbapenem-resistant <i>Acinetobacter</i> species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021Pete Kinross, Carlo Gagliotti, Hanna Merk, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|March 28, 2014
Drug-resistant Salmonella enterica serotype Kentucky in EuropeTherese Westrell, Dominique L Monnet, Céline Gossner, et al.
British Journal of Clinical Pharmacology|May 4, 2006
Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospitalArno Muller, Dominique L Monnet, Daniel Talon, et al.
The Lancet. Infectious Diseases|December 3, 2014
Antibiotic use worldwideLiselotte Diaz Högberg, Arno Muller, Anna Zorzet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2015
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015Barbara Albiger, Corinna Glasner, Marc J Struelens, et al.
Diagnostic Microbiology and Infectious Disease|April 22, 2014
Antimicrobial resistance surveillance in Europe: regional pooling of national data from a small number of sites can be misleadingLiselotte Diaz Högberg, Anna-Pelagia Magiorakos, Ole E Heuer, et al.
Antimicrobial Resistance and Infection Control|February 16, 2013
The rise of carbapenem resistance in Europe: just the tip of the iceberg?Anna-Pelagia Magiorakos, Carl Suetens, Dominique L Monnet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 19, 2021
Decrease in community antibiotic consumption during the COVID-19 pandemic, EU/EEA, 2020Liselotte Diaz Högberg, Vera Vlahović-Palčevski, Cátia Pereira, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 15, 2024
Measuring hospital antibiotic consumption in EU/EEA countries: comparison of different metrics, 2017 to 2021Igor Rubinić, Vivian H Leung, Liselotte Diaz Högberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 13, 2020
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant <i>Acinetobacter baumannii</i> in Europe, 2019Felix Lötsch, Barbara Albiger, Dominique L Monnet, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 18, 2022
Large increase in bloodstream infections with carbapenem-resistant <i>Acinetobacter</i> species during the first 2 years of the COVID-19 pandemic, EU/EEA, 2020 and 2021Pete Kinross, Carlo Gagliotti, Hanna Merk, et al.
Pageof 11